STA-4783 and Paclitaxel for Treatment of Solid Tumors
NCT00088114
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
STA-4783/paclitaxel
Sponsor
Synta Pharmaceuticals Corp.